News

Curative-intent multimodality treatment—combining local treatments such as surgery or radiotherapy with systemic therapy—is ...
Background The long-acting monoclonal antibody nirsevimab and respiratory syncytial virus (RSV) vaccines became available for prevention of severe RSV-associated disease in 2023. While clinical trials ...
Introduction Paternal prepubertal passive smoke exposure may increase the risk of childhood asthma. However, its association ...
Introduction Breathlessness is a common cause of hospital admission globally and is associated with high mortality, ...
A common eligibility criterion in respiratory clinical trials is a per cent-predicted forced expiratory volume in 1 second ...
The 2024 British Thoracic Society/ National Institute for Health and Care Excellence/ Scottish Intercollegiate Guidelines Network asthma guidelines recommend anti-inflammatory reliever (AIR)-based ...
1 Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium 2 Department of Respiratory Medicine, OLV Ziekenhuis, Aalst, Belgium 3 Department of Respiratory Medicine, AZ Groeninge, ...
Inhaled corticosteroids (ICSs) benefit patients with chronic obstructive pulmonary disease at high risk of exacerbations with raised blood eosinophil count (BEC). Emerging evidence suggests current ...
Respiratory syncytial virus (RSV) is the most common viral pathogen associated with acute lower respiratory tract infection (LRTI) in children under 5 years of age. Severe RSV disease is associated ...
Thoracic Oncology Unit, Department of Respiratory Medicine, Glenfield Hospital, Leicester, UK Correspondence to: Dr M D Peake Thoracic Oncology Unit and Institute for Lung Health, Department of ...
Health Behaviour Unit, Department of Epidemiology and Public Health, University College London, London WC1E 6BT, UK Elizabeth Holloway, Research Physiotherapist, Department of Epidemiology and Public ...
5 Division of Respiratory Medicine, Nottingham City Hospital, Nottingham NG5 1PB, UK Correspondence to: Dr J T Macfarlane, Respiratory Infection Research Group, Respiratory Medicine, Nottingham City ...